<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2015112525235N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2016-11-04</date_registration>
      <primary_sponsor>Vice Chancellor for Reseach of Shahid Beheshti University of Medical Science</primary_sponsor>
      <public_title>Comparison of  anesthetic drugs  to create deep  sedation.</public_title>
      <acronym></acronym>
      <scientific_title>Compare the effects of low-dose combination of anesthetic drugs (including fentanyl, propofol, midazolam, ketamine and lidocaine) with the usual dose of propofol in creating deep sedation</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2015-03-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>122</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/21130</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Patients were divided by blocked randomization method.</study_design>
      <phase>2</phase>
      <hc_freetext>Procedural Sedation and Analgesia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intervention group patients are given low doses of sedative drugs, including propofol  in a dose of 0.5 mg per kilogram of body weight,  ketamine 0.2 to 0.25 mg per kilogram of body weight, midazolam at doses of 0.01 to 0.02 mg per kilogram of body weight, fentanyl 0.5 to 1 microgram  per kg of body weight and lidocaine 0.5 to 1 mg per kilogram of body weight Intravenously . Intervention 2: Control group: patients in control group are given  propofol at a dose of 1 mg per kilogram and fentanyl 1 microgram per kilogram of body weight Intravenously .</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Shahram Shokrzadeh.MD</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Emam Hossein Hospital, Shahid Madani Ave, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>-</zip>
        <telephone>+98 21 73430</telephone>
        <email>shahram.shokrzadeh@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Science</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Afshin Amini . MD</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Emam Hossein Hospital, Shahid Madani Ave, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>-</zip>
        <telephone>+98 21 73430</telephone>
        <email>a.amini@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical science</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: Patients admitted to the emergency department of Emam Hossein hospital over 15 years to 60 years of age and they need Procedural sedation and analgesia (PSA) &#13;
Exclusion criteria: previous allergy to drugs used in the study; sensitivity to egg or soy products; Hemodynamic Instability; pregnancy; drug interactions; increased intracranial pressure (ICP)</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intervention group patients are given low doses of sedative drugs, including propofol  in a dose of 0.5 mg per kilogram of body weight,  ketamine 0.2 to 0.25 mg per kilogram of body weight, midazolam at doses of 0.01 to 0.02 mg per kilogram of body weight, fentanyl 0.5 to 1 microgram  per kg of body weight and lidocaine 0.5 to 1 mg per kilogram of body weight Intravenously .</i_keyword>
      <i_keyword>Control group: patients in control group are given  propofol at a dose of 1 mg per kilogram and fentanyl 1 microgram per kilogram of body weight Intravenously .</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The needed time for recovery from deep sedation. Timepoint: Every 30 seconds since the beginning of deep sedation. Method of measurement: The interval time between induction of sedation (Ramsay score 6) and recovery (Ramsy score of 2.</prim_outcome>
      <prim_outcome>The depth of sedation. Timepoint: Every 30 seconds since the beginning of sedation. Method of measurement: the depth of sedation according to the Ramsay  score.</prim_outcome>
      <prim_outcome>The time required to create deep sedation. Timepoint: Every 30 seconds. Method of measurement: Since the beginning of sedative drugs to achieve deep sedation (Ramsay score equal to 6).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Cardiac arrhythmia. Timepoint: continuously since the beginning of sedation. Method of measurement: Cardiac monitoring.</sec_outcome>
      <sec_outcome>Arterial blood pressure. Timepoint: Before prescription of drugs, then every 5 minutes until recovery time. Method of measurement: Using the sphygmomanometer.</sec_outcome>
      <sec_outcome>Physician and patient's satisfaction. Timepoint: after the procedure. Method of measurement: By questionnaire.</sec_outcome>
      <sec_outcome>Arterial blood oxygen saturation. Timepoint: Continuously since the beginning of sedation. Method of measurement: Pulse oximetry.</sec_outcome>
      <sec_outcome>Vomiting. Timepoint: since the beginning of sedation until full recovery. Method of measurement: Observation.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id>-</sec_id>
        <issuing_authority>-</issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice Chancellor for Reseach of Shahid Beheshti University of Medical Science</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2015-02-15</approval_date>
        <contact_name>Ethic Commitee of Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>Shahid Beheshti University of Medical Science, Next to the Ayatollah Taleghani Hospital, Martyr Arabi Street, Yemen Street, Martyr Chamran highway, Tehran Tehran  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
